|
Volumn 36, Issue 7, 2004, Pages 2120-2121
|
Therapeutic implication of quantitative pp65 antigen assay in living renal transplant in a high seroendemic population
b
Chandigarh India 160023
*
(India)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIGEN PP65;
ANTIVIRUS AGENT;
GANCICLOVIR;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
THYMOCYTE ANTIBODY;
UNCLASSIFIED DRUG;
VIRUS ANTIGEN;
ANTIGEN DETECTION;
ANTIVIRAL ACTIVITY;
BLOOD SAMPLING;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
DIAGNOSIS;
ENDEMIC DISEASE;
GRAFT REJECTION;
HUMAN;
IMMUNOASSAY;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT;
KIDNEY TRANSPLANTATION;
MONITORING;
POPULATION RESEARCH;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
SYMPTOM;
CYTOMEGALOVIRUS INFECTIONS;
HUMANS;
INDIA;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
PHOSPHOPROTEINS;
REPRODUCIBILITY OF RESULTS;
RETROSPECTIVE STUDIES;
VIRAL MATRIX PROTEINS;
|
EID: 7044237021
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.08.106 Document Type: Conference Paper |
Times cited : (3)
|
References (5)
|